Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Plan a withdrawal strategy post-rebalancing for SP 500 holdings to sustain income while managing risk.
24,074 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
YieldMax's MSTY ETF continues to pay weekly distributions while its NAV slides, signaling rising risk for investors. ...
DAIO's Q4 2025 earnings offer more than headlines. This in-depth look translates the transcript into actionable insig...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Oppenheimer boosts its Palo Alto Networks price target to $275 citing strong demand for the Idira identity security p...
Drees Homes announces a bold shift toward operational leadership to guide the builder through tighter lending conditi...
Finance of America named three senior executives to steer brand, communications and product as it scales retirement-f...
Meta Platforms is nudging into cloud computing, aiming to monetize idle compute and AI-ready infrastructure. This art...
In a high-stakes bidding war, Netflix may have positioned itself to win by losing the bid for Warner Bros Discovery. ...
Airbnb hosting has evolved from a side gig to a steady income for many homeowners. But as airbnb services have pushed...
USOI, a Credit Suisse X-Links Crude Oil ETN, pays sizable monthly distributions but sits in the risky space of unsecu...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...